NT_1170x120_1-11-18

IMS Health

QuintilesIMS adopts IQVIA as new name

QuintilesIMS adopts IQVIA as new name

DANBURY, Conn., and  RESEARCH TRIANGLE PARK, N.C. — Global health care and pharmaceutical information specialist QuintilesIMS has changed its name to IQVIA. The IQVIA name became effective as of Nov. 6, the company said. Plans call for IQVIA equity shares to trade on the New York Stock Exchange under the ticker symbol “IQV” starting on

IMS Health, Quintiles wrap up merger

IMS Health, Quintiles wrap up merger

DANBURY, Conn., and RESEARCH TRIANGLE PARK, N.C. — IMS Health and Quintiles have combined to form a new global health care information and service provider, QuintilesIMS. The companies on Monday said they have completed their merger, an all-stock merger-of-equals transaction announced in May. The agreement united IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc.

IMS Health, Quintiles unveil merger deal

IMS Health, Quintiles unveil merger deal

DANBURY, Conn., and RESEARCH TRIANGLE PARK, N.C. — Health care and pharmaceutical information specialists IMS Health Holdings Inc. and Quintiles Transnational Holdings Inc. plan to merge. The companies said Tuesday that the deal is an all-stock merger of equals transaction, with the combined company to be named Quintiles IMS Holdings Inc. Plans call for the

Health care turmoil creates opportunity for Rx

Health care turmoil creates opportunity for Rx

More than five years after enactment of the Affordable Care Act, a measure designed to extend coverage to the uninsured and control expenditures, the turmoil in the U.S. health care system shows no signs of abating. Millions of Americans are still without health coverage, and health care costs continue to increase faster than the overall

Global drug spending to climb steadily

Global drug spending to climb steadily

DANBURY, Conn. — More than half of the world’s population will live in countries where medicine use will exceed one dose per person per day by 2020, up from 31% a decade ago, as the “medicine use gap” between developed and pharmerging markets narrows, the IMS Institute for Healthcare Informatics projects. Global drug spending is

Walgreens: Pharmacist interventions pay off

Walgreens: Pharmacist interventions pay off

DEERFIELD, Ill. — New research by Walgreens finds that pharmacist interventions can play a key role in improving patients’ medication adherence and achieving related health care benefits. Walgreens said Monday that the study, titled “Improving Medication Adherence and Healthcare Outcomes in a Commercial Population Through a Retail Pharmacy Chain,” is one of the first to

Rite Aid’s Thompson honored at Total Store Expo

DENVER — Pharmacy veteran Robert Thompson received the Harold W. Pratt Award, considered pharmacy’s highest honor, from the National Association of Chain Drug Stores during a business program at the 2015 NACDS Total Store Expo. Thompson’s pharmacy career spans nearly four decades. Joining Rite Aid Corp. in 2004, he served in a variety of management

U.S. drug spending, scripts reach new highs

U.S. drug spending, scripts reach new highs

PARSIPPANY, N.J. — Specialty medications helped drive a double-digit gain in total spending on medicines in the United States for 2014, as well as record volume in prescriptions dispensed, according to the IMS Institute for Healthcare Informatics, a unit of IMS Health. Last year, U.S. spending on medicines rose 10.3% on a real per capita

Generics drugs loom larger than ever in health care

Generics drugs loom larger than ever in health care

NEW YORK — As the nation becomes more focused on affordable health care, generic drug companies are carving out a larger share of the U.S. market for prescription drugs. Perhaps the most significant sign of this continuing shift to generic drug utilization shows up in the market share data for actual prescriptions dispensed, brands compared